POCRAME SAS
MARSEILLE / c/o IHU MED INFECTION
POCRAME has invented a mobile laboratory terminal named MEPHILAB for the rapid and delocalized syndromic diagnosis of acute infections and their differential diagnosis. This laboratory terminal, after a validated training including by people without medical knowledge required through a touch screen can help transcribe the symptoms of the patient. Once this collection of clinical signs done, the software recommends the biological tests to be performed according to a decision algorithm. They are made from a drop of blood, saliva or urine deposited on a reagent cartridge. The terminal is easily deployed in all isolation situations (maritime, extreme terrestrial medical isolation, population migration context ...). these tests must answer 3 questions: is the patient contagious and isolated? Should the patient be hospitalized, should he receive special treatment in an emergency? Secondary produtc : MEPHIBOX for Individual Protection Equipt |
|||||||||
Business axis : |
Diagnostic Equipements de laboratoire mobile Plasturgie |
||||||||
Category : | TPE | ||||||||
Legal form : | SAS | ||||||||
Website : | www.pocrame.com | ||||||||
Turnover : |
128,000.00 K€ |
||||||||
Reference technologies : |
Point Of CARE = POC expérience dans la biologie délocalisée. gestion de la prévention,du diagnostic et du traitement en maladies infectieuses |